As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 5/15/06  Brennan Murray                    4          Director²   1:6K   Alaunos Therapeutics, Inc.        Section16 Direct/FA      
 4/28/06  Cannon James Anthony              4          Director²   1:6K   Alaunos Therapeutics, Inc.        Section16 Direct/FA      
 4/28/06  Bagley Richard E                  4          Dir.,Off.²  1:9K   Alaunos Therapeutics, Inc.        Section16 Direct/FA      
 4/27/06  McInerney Timothy                 4          Director²   1:7K   Alaunos Therapeutics, Inc.        Section16 Direct/FA      
 4/27/06  Fowler Wyche                      4          Director²   1:6K   Alaunos Therapeutics, Inc.        Section16 Direct/FA      
 4/27/06  Gale Robert Peter                 4          Officer²    1:8K   Alaunos Therapeutics, Inc.        Section16 Direct/FA      
 4/27/06  Weiser Michael                    4          Director²   1:6K   Alaunos Therapeutics, Inc.        Section16 Direct/FA      
 4/27/06  Lewis Jonathan                    4          Dir.,Off.²  1:10K  Alaunos Therapeutics, Inc.        Section16 Direct/FA      
 4/27/06  Fragin Gary S                     4          Director²   1:6K   Alaunos Therapeutics, Inc.        Section16 Direct/FA      
 4/26/06  Alaunos Therapeutics, Inc.        424B3                  1:69K                                    Toppan Merrill/FA        
 4/26/06  Alaunos Therapeutics, Inc.        8-K:1,8,9   4/26/06    3:85K                                    Toppan Merrill/FA        
 3/20/06  Alaunos Therapeutics, Inc.        DEF 14A     4/26/06    1:283K                                   Toppan Merrill/FA        

____________
¹	Filing/Form Types:
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	424B3	Prospectus – New Facts or Events.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.